September 28, 2026

NanoViricides Launches Patient Enrollment in Phase II Ebola Trial

Vinhomes Expands Integrated City Model From Vietnam to Global Markets
September 11, 2026

Vinhomes Expands Integrated City Model From Vietnam to Global Markets

September 8, 2026

NanoViricides Registers Phase II Ebola Trial for Oral Antiviral NV-387 in DRC

August 18, 2026

NanoViricides Prepares for Phase II Ebola Trial of Oral Drug Candidate in DRC

August 13, 2026

GeoVax Offers Vaccine Expertise as Congo’s Ebola Outbreak Escalates

August 10, 2026

NanoViricides Gets Approval for Phase II Ebola Trial in DRC, Offering Oral Treatment Option

July 28, 2026

NanoViricides Seeks Regulatory Approval for Ebola Trial of NV-387 Oral Gummies in DRC

July 22, 2026

NanoViricides Seeks Approval for Phase II Ebola Trial in DRC Amid Ongoing Outbreak